Endoscopic injection of lauromacrogol sclerotherapy for esophageal variceal hemorrhage caused by rupture / 中国内镜杂志
China Journal of Endoscopy
; (12): 1-4, 2016.
Article
in Zh
| WPRIM
| ID: wpr-621289
Responsible library:
WPRO
ABSTRACT
Objective To investigate the effect of different endoscopic sclerotherapy for esophageal variceal bleed-ing caused by rupture. Methods 66 cases of liver cirrhosis with esophageal variceal bleeding were randomly divided into treatment group A, endoscopic lauromacrogol sclerotherapy group B and endoscopic aethoxysklerol 1% German agents in treatment of group C, then observe the successful hemostasis, the curative effect and follow-up of patients with varices, bleeding, fever and other adverse conditions. Results Group B and group C with success rate of hemostasis has obvious advantages compared with group A, 0.05, the difference was not statistically significant; adverse conditions such as fever, ulcers, pain in group B was less than that in group C, <0.05, the difference was statistically significant. Conclusion Endoscopic lauromacrogol injection sclerotherapy for esophageal variceal bleeding is a safe, fast speed, timely, effective and repeatable treat-ment, it is worthy of promoting clinical application.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
China Journal of Endoscopy
Year:
2016
Type:
Article